106 related articles for article (PubMed ID: 10844561)
21. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
22. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests.
Naisbitt DJ
Toxicology; 2004 Jan; 194(3):179-96. PubMed ID: 14687965
[TBL] [Abstract][Full Text] [Related]
23. The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
Clin Pharmacol Ther; 2004 Dec; 76(6):579-87. PubMed ID: 15592329
[TBL] [Abstract][Full Text] [Related]
24. N-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.
Uetrecht JP; Shear NH; Zahid N
Drug Metab Dispos; 1993; 21(5):830-4. PubMed ID: 7902244
[TBL] [Abstract][Full Text] [Related]
25. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
[TBL] [Abstract][Full Text] [Related]
26. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
27. The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
Clin Pharmacol Ther; 2004 Oct; 76(4):313-22. PubMed ID: 15470330
[TBL] [Abstract][Full Text] [Related]
28. The innate immune system in delayed cutaneous allergic reactions to medications.
Bellón T; Blanca M
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):292-8. PubMed ID: 21659858
[TBL] [Abstract][Full Text] [Related]
29. N-Acetylation of paraphenylenediamine in human skin and keratinocytes.
Kawakubo Y; Merk HF; Masaoudi TA; Sieben S; Blömeke B
J Pharmacol Exp Ther; 2000 Jan; 292(1):150-5. PubMed ID: 10604942
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.
Roychowdhury S; Svensson CK
AAPS J; 2005 Dec; 7(4):E834-46. PubMed ID: 16594635
[TBL] [Abstract][Full Text] [Related]
31. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
[TBL] [Abstract][Full Text] [Related]
32. Drug-elicited systemic allergic (contact) dermatitis--update and possible pathomechanisms.
Thyssen JP; Maibach HI
Contact Dermatitis; 2008 Oct; 59(4):195-202. PubMed ID: 18844694
[TBL] [Abstract][Full Text] [Related]
33. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
34. Haptenation of sulfonamide reactive metabolites to cellular proteins.
Manchanda T; Hess D; Dale L; Ferguson SG; Rieder MJ
Mol Pharmacol; 2002 Nov; 62(5):1011-26. PubMed ID: 12391263
[TBL] [Abstract][Full Text] [Related]
35. Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
Chun JS; Yun SJ; Kim SJ; Lee SC; Won YH; Lee JB
Clin Exp Dermatol; 2009 Dec; 34(8):e798-801. PubMed ID: 19778310
[TBL] [Abstract][Full Text] [Related]
36. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
Roudier C; Caumes E; Rogeaux O; Bricaire F; Gentilini M
Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
[TBL] [Abstract][Full Text] [Related]
37. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III: Effect of diabetes.
Coleman MD; Simpson J; Jacobus DP
Biochem Pharmacol; 1994 Oct; 48(7):1341-7. PubMed ID: 7945431
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.
Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
Clin Pharmacol Ther; 1996 Mar; 59(3):332-40. PubMed ID: 8653996
[TBL] [Abstract][Full Text] [Related]
39. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
[TBL] [Abstract][Full Text] [Related]
40. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Bluhm RE; Adedoyin A; McCarver DG; Branch RA
Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
